Switzerland

Peripal device approved in Europe for at-home peritoneal dialysis
Renal insufficiency is an expensive condition to treat due to the high cost of hospital dialysis treatment. Peripal AG, a Swiss startup, has received approval for the European market for its PeriSafe device for at-home dialysis.
Alex Guest Wed, 27/03/2019 - 10:24

SOPHiA GENETICS raises USD 77 million to build US business

SOPHiA GENETICS has closed a $77 million funding round led by Generation Investment Management, with participation from Idinvest Partners, alongside existing investors including Balderton Capital and Alychlo.